TABLE 3.
Nonclinical Projects |
Clinical Projects |
|||||
RCDC Topic | No. | Total Funding (% Extramural Funding) | Median Cost per Project (25th, 75th Percentiles) | No. | Total Funding (% Extramural Funding) | Median Cost per Project (25th and 75th Percentiles) |
Cardiovascular | 1,913 | 865,499 (35%) | 374 (270, 414) | 1,005 | 539,545 (22%) | 379 (142, 658) |
Atherosclerosis | 393 | 243,991 (10%) | 375 (303, 414) | 271 | 160,713 (7%) | 401 (198, 722) |
CAD | 440 | 221,791 (9%) | 380 (323, 420) | 267 | 156,696 (6%) | 422 (200, 721) |
Heart disease | 1,258 | 595,073 (24%) | 375 (286,417) | 727 | 410,409 (17%) | 386 (147, 685) |
Hypertension | 231 | 105,746 (4%) | 370 (312, 401) | 111 | 50,652 (2%) | 371 (151, 594) |
Lung | 697 | 325,329 (13%) | 376 (293, 410) | 605 | 283,649 (12%) | 375 (137, 610) |
COPD | 55 | 58,142 (2%) | 410 (346, 1,730) | 84 | 44,767 (2%) | 372 (142, 703) |
Asthma | 94 | 40,732 (2%) | 373 (249, 400) | 144 | 79,092 (3%) | 407 (160, 750) |
ARDS | 110 | 61,255 (3%) | 384 (335, 410) | 82 | 29,665 (1%) | 326 (135, 415) |
Cystic fibrosis | 42 | 21,253 (1%) | 371 (326, 475) | 37 | 17,928 (1%) | 385 (173, 648) |
Sleep | 55 | 16,969 (1%) | 367 (230, 393) | 97 | 51,527 (2%) | 405 (189, 607) |
Hematology | 406 | 165,228 (7%) | 370 (191, 410) | 295 | 139,989 (6%) | 375 (140, 464) |
Sickle cell | 21 | 9,325 (<1%) | 338 (139, 458) | 60 | 28,774 (1%) | 303 (125, 451) |
Cooley anemia | 9 | 4,949 (<1%) | 394 (373, 429) | 9 | 8,112 (<1%) | 411 (390, 1,327) |
Definition of abbreviations: ARDS = acute respiratory distress syndrome; CAD = coronary artery disease; COPD = chronic obstructive pulmonary disease.
All costs are in units of $1,000. All data were obtained from the NIH Research Portfolio Online Reporting Tools (RePORT). Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) are found at http://report.nih.gov/categorical_spending.aspx. RCDC topics are not necessarily exclusive of one another (hence total percentages exceed 100). Clinical projects are those categorized in RCDC as “Clinical Research” or “Clinical Trials Total NHLBI extramural funding in fiscal year 2010 was $2,441,772,050. Numbers of projects, total funding in each RCDC area, and median (25th, 75th percentiles) costs per project were calculated using the SAS 9.2 “Proc Tabulate” procedure.